Share on LinkedInShare on LinkedIn

ARTICLE · 23 APRIL 2024

Lost In Interpretation: How Claim Construction Doomed AlexSam's Case Against Cigna

. . . However, the qualifying language, "unmodified existing," proved to be an unfortunate choice of words. . . .

JapanIntellectual Property

. . . However, the qualifying language, "unmodified existing," proved to be an unfortunate choice of words. . . .

In AlexSam, Inc. v. Cigna Corp., et al., No. 2022-1599 (Fed. Cir. Apr. 1, 2024) ("Decision"), the Federal Circuit affirmed the district court's ruling on summary judgment that Cigna did not infringe the asserted claims of AlexSam's U.S. Patent No. 6,000,608 (the '608 Patent), which issued on December 14, 1999. AlexSam filed its complaint against Cigna on March 18, 2020—three years after the '608 patent expired—seeking pre-expiration damages for Cigna's alleged infringement.

The claims of the '608 patent are directed to a "multifunction" system that allows healthcare providers to access and retrieve a patient's healthcare data simply by reading the patient's credit or debit card with standard point-of-sale equipment. The claimed system therefore provides an integrated system in which both payment and medical data processing functions utilize the same

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from